These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39078403)

  • 1. Experimental Designs for Multicomponent Interventions in Kidney and Cardiometabolic Diseases.
    Rossing P
    J Am Soc Nephrol; 2024 Oct; 35(10):1438-1441. PubMed ID: 39078403
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin: novel roles for a new hormone - Emerging therapies in cardiometabolic and renal diseases.
    Melander O
    J Intern Med; 2017 Oct; 282(4):281-283. PubMed ID: 28929632
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
    Cavalcanti Neto MP; Aquino JS; Romão da Silva LF; de Oliveira Silva R; Guimarães KSL; de Oliveira Y; de Souza EL; Magnani M; Vidal H; de Brito Alves JL
    Pharmacol Res; 2018 Apr; 130():152-163. PubMed ID: 29410236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of physical exercises in internal diseases].
    Moshkov VN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (6):62-5. PubMed ID: 7039094
    [No Abstract]   [Full Text] [Related]  

  • 5. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
    Aron-Wisnewsky J; Clément K
    Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to Treatment.
    Ursini F; Ruscitti P
    Rev Recent Clin Trials; 2018; 13(3):162-163. PubMed ID: 30084330
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.
    Murphy AJ; Febbraio MA
    Nat Rev Immunol; 2021 Oct; 21(10):669-679. PubMed ID: 34285393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training the Next Generation of Cardiometabolic Specialists.
    McCarthy CP; Chang LS; Vaduganathan M
    J Am Coll Cardiol; 2020 Mar; 75(10):1233-1237. PubMed ID: 32164896
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving quality in cardiometabolic medicine real-world evidence.
    Coles B; Tyrer F; Khunti K
    Prim Care Diabetes; 2019 Apr; 13(2):188. PubMed ID: 30446359
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care.
    Rangaswami J; Tuttle K; Vaduganathan M
    Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e007264. PubMed ID: 33176463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic kidney disease--update 2014].
    Wanner C; Ketteler M
    Dtsch Med Wochenschr; 2014 Feb; 139(6):261-3. PubMed ID: 24473844
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of educational sessions on cardiometabolic comorbidities. Awareness among psoriasis patients.
    Mota F; Selores M; Torres T
    Actas Dermosifiliogr; 2016; 107(6):539-41. PubMed ID: 26925530
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging potential of therapeutic targeting of autophagy and protein quality control in the management of cardiometabolic diseases.
    Ren J; Zhang Y
    Biochim Biophys Acta; 2015 Feb; 1852(2):185-7. PubMed ID: 25446986
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel therapeutic approaches to chronic kidney disease.
    Dhaun N; Webb DJ
    Br J Clin Pharmacol; 2013 Oct; 76(4):491-4. PubMed ID: 24073602
    [No Abstract]   [Full Text] [Related]  

  • 15. [The medical service oriented towards renal, bladder and metabolic diseases. (Convalescent Service)].
    Rein Foie; 1967; 10():323-4. PubMed ID: 6083329
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of fibrates in chronic kidney disease and diabetes mellitus.
    Kahn MR; Robbins MJ; Kim MC; Fuster V
    Nat Rev Cardiol; 2013 Sep; 10(9):547. PubMed ID: 23900360
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid-lowering agents in chronic kidney disease: do fibrates have a role?
    Huang Y; Hu Y
    Nat Rev Cardiol; 2013 Sep; 10(9):547. PubMed ID: 23900358
    [No Abstract]   [Full Text] [Related]  

  • 18. Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Mathew RO; Bangalore S; Sidhu MS; Fleg JL; Maddux FW
    Kidney Int; 2018 Apr; 93(4):787-788. PubMed ID: 29571453
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.
    Vijayaraghavan K; McCullough PA; Singh B; Gupta M; Enas E; Mohan V; Misra A; Deedwania P; Brinton EA;
    Cardiorenal Med; 2019; 9(4):240-251. PubMed ID: 31079117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World kidney day 2016 Averting the legacy of kidney disease--- focus on childhood.
    Ingelfinger JR; Kalantar-Zadeh K; Schaefer F;
    Clin Nephrol; 2016 Feb; 85(2):63-9. PubMed ID: 26772048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.